Philips adds to its cardiology suite of solutions at ACC 2022 with
innovations to help improve patient outcomes, experiences, and care
pathway effectiveness
March 31, 2022
Innovations designed to seamlessly work together, strengthen
clinical confidence, build efficiency throughout the care pathway,
and improve cardiac care experiences
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced new additions to its innovative integrated portfolio of
cardiology solutions at the American College of Cardiology’s Annual
Scientific Session & Expo (ACC 2022). Philips’ cardiology
portfolio offers solutions for coronary artery disease, structural
heart disease, arrhythmia and heart failure. It integrates
diagnostic and interventional imaging, treatment devices, and
cardiac patient monitoring solutions at each point in the patient
journey with the aim to improve clinical outcomes, patient and
staff experiences, and care pathway effectiveness.
Cardiovascular disease continues to be the number one healthcare
challenge globally and is one of the leading causes of death
worldwide [1]. The costs associated with cardiovascular diseases
are rising significantly, with an expected growth in cost of 101%
by 2035 [2]. Worldwide, clinicians need to balance the delivery of
high-quality care for a growing volume of complex patients with
constantly improving departmental efficiency.
Adding to the strength and depth of its cardiology portfolio, at
ACC.22 Philips is launching two major innovations. Philips
Ultrasound Workspace, an industry leading vendor-neutral
echocardiography image analysis and reporting solution that can be
accessed via the web, allows clinicians to create seamless
diagnostic workflows from the ultrasound exam room to the reporting
room and beyond. Philips also announced the global availability of
a new Ambient Experience solution connecting to Philips Image
Guided Therapy System - Azurion, which aims to reduce patient
anxiety during interventional procedures. Ambient Experience with
FlexVision display offers patients a calming multi-sensory
experience while staff prepare them for their procedure.
Philips Ultrasound Workspace: Next generation
echocardiography solutionBy offering cardiologists a
consistent set of AI-driven automated image analysis and
quantification tools for use at any point in the care pathway,
together with the ability to perform longitudinal patient studies,
Philips Ultrasound Workspace helps to improve productivity and
consistency while also enhancing diagnostic quality. Irrespective
of location [3], with Ultrasound Workspace, the same user interface
and AI-enabled image analysis and quantification tools are now
accessible to help speed up quantitative measurements such as left
ventricular ejection fraction, increase diagnostic confidence, and
improve inter-observer and intra-observer variability.
Introducing the Philips Ambient Experience to
interventional roomsDebuting at ACC.22 is Ambient
Experience with FlexVision display. It offers patients undergoing
an interventional procedure a calming multi-sensory experience
while staff prepare them for their procedure, prior to the display
being used for the actual intervention. It also allows patients and
interventional team members to adapt the room’s ambient lighting
and sound to add to the overall feeling of calm, especially during
the patient entry and preparation phases of procedures. Aimed at
reducing patient anxiety during interventional procedures, Ambient
Experience, leveraging the Azurion’s FlexVision display, has the
potential to improve the patient and staff experience, positively
impact outcomes, and enhance workflows and productivity.
At ACC, Philips will also spotlight the latest cardiovascular
features to Enterprise Performance Analytics – Performance Bridge –
giving cardiovascular service line managers access to near
real-time data on departmental performance through easy-to-use
interactive vendor-neutral dashboards.
With these newest enhancements, users now have access to
critical metrics to support operational performance monitoring in a
minimally invasive procedural setting such as the interventional
suite, providing data on procedure volumes, room utilization,
procedure duration and lab turnaround time. Users can also access
key metrics designed to support operational performance monitoring
in a non-invasive procedural setting such as cardiac imaging
suites, most notably echocardiography, with access to data on
procedure volumes, modality/machine utilization, study type counts
and report turnaround time.
This newest release further demonstrates Philips’ commitment
working closely together with healthcare providers to bring
together the right combination of services and tools to measure and
monitor key areas to help drive continuous improvement, optimized
operations, enhanced workflow efficiencies and improved patient
outcomes.
Also highlighted at ACC.22 is Philips Image-Guided Therapy
System - Azurion, the company’s advanced image-guided therapy
platform that supports providers in performing procedures easily
and confidently with a unique user experience.
Philips is also showcasing its complete portfolio of ambulatory
cardiac diagnostic and monitoring services, as well as stroke
care solutions, that provide industry-leading data analysis
and management to help make care delivery more comprehensive,
accurate and efficient.
New late-breaking clinical session on CIED patient
careOn Sunday, April 3 at 13:15-13:25 ET in Main Tent |
Hall D, Sean Pokorney, M.D., Assistant Professor of Medicine at
Duke University School of Medicine (USA) and member of the Duke
Clinical Research Institute, will present on low rates of
guideline-directed care associated with higher mortality in
patients with infection of pacemakers and implantable cardioverter
defibrillators. Philips supports physicians with Lead Management
solutions through a broad portfolio of tools designed for safety
and predictability, including both laser and mechanical lead
extraction devices.
To connect with experts and learn more about the Philips
cardiology solutions that strengthen clinical confidence and build
efficiency throughout the care pathway stop by Philips booth #1121.
For a full calendar of events, as well as general information about
Philips’ presence at the show, visit www.philips.com/ACC. Visit the
Philips Industry Hub to experience innovative cardiac solutions and
follow the #ACC2022 conversation on @PhilipsLiveFrom throughout the
event.
[1] European Cardiovascular Disease Statistics 2017.[2] RTI
International for the American Heart Association. Projections of
Cardiovascular Disease Prevalence and Costs: 2015–2035. [3] Remote
access requires a secure VPN connection.
For further information, please contact:
Joost Maltha Philips Global Press Office Tel:
+31 6 10 55
8116 Email: joost.maltha@philips.com
Fabienne van der FeerPhilips Image Guided TherapyTel: + 31 622
698 001E-mail: fabienne.van.der.feer@philips.com
About Royal Philips Royal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being, and enabling better
outcomes across the health continuum – from healthy living and
prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer
insights to deliver integrated solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2020
sales of EUR 17.3 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Philips Ambient Experience and FlexVision display
- Philips Ultrasound Workspace
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
Von Mär 2023 bis Mär 2024